Skip to content
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECH
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABS
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • VIC-HUG
    • Recent Press
  • CAREERS

COVID Vaccines, Therapeutics, Variants, Long COVID, Ability To Tackle the Next Pandemic

  • Posted on May 12, 2022
Director of the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital, Dr. Mark Poznansky, joins Dr. Marc Siegel on Sirius XM Doctor Radio and discusses the latest information on vaccine development, current therapeutics, Long COVID, individual responsibility in preventing the spread of COVID, and the United States’ ability to tackle the next pandemic.
Listen Via Pandora
FacebookTwitter

Recommended Posts

Publication from the Gemechu lab – Intratumoral immune cell manipulations as a strategy to enhance cancer vaccine efficiency
Alexis Jolly, VIC summer student, presents innovative technology at the international SPIE Photonics West Conference following summer at VIC, Wellman Centre, and MGH
Saumya Maheshwari and James Aspden of the Sîrbulescu lab share the 2024 Arthur Fonville Award for their research in stroke!
Dr. Mark Poznansky speaks on B cell therapy in the context of regenerative medicine at the 2024 First Look at the World Medical Innovation Forum.
Vaccine & Immunotherapy Center
Accelerating discovery and development of new products addressing unmet clinical need.
Facebook-f Twitter Youtube

INFORMATION

  • CAREERS
  • Directions
  • Advisors
  • Management
  • Collaborators
  • Support VIC

CONTACT

149 13th Street, 5th Floor
Charlestown Navy Yard,
MA 02129-2020

Phone  :  1-617-643-2098
Email    :  VIC@partners.org

© 2023 VACCINE & IMMUNOTHERAPY CENTER. ALL RIGHTS RESERVED |  Site by OLP